© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt
(Reuters) -European stocks hit record highs on Thursday as optimism grew around a global stimulus-fuelled economic rebound after the U.S. Federal Reserve signalled that it was in no hurry to tighten its monetary policy. The pan-European index rose 0.3%, according to Google (NASDAQ:) Finance data, adding to gains notched earlier this week when the index erased all of its pandemic-driven losses. Fed officials remain wary about the ongoing risks of the coronavirus pandemic and are committed to bolstering the economy until its recovery is more secure, minutes of the central bank’s latest policy meeting released on Wednesday showed. “A dovish set of meeting minutes from the Federal Reserve has further reassured investors that Jay Powell and the gang won’t be turning off the stimulus taps any time soon,” Connor Campbell, an analyst at Spredex, wrote in a morning note. Market participants will now turn their focus to the European Central Bank, which is expected to release its March meeting minutes at 1130 GMT. Investors broadly looked past news that several European countries had announced restrictions on the use of AstraZeneca (NASDAQ:)’s COVID-19 vaccine in younger people, after a link was found to very rare blood clots. The British drugmaker’s shares climbed 1.3%.
Holland-based technology investor Prosus (OTC:) NV rose slightly after it sold 2% of China’s Tencent Holdings (OTC:) Ltd for $14.7 billion in the world’s largest-ever block trade. Chemicals maker Johnson Matthey (LON:) jumped almost 4% after it forecast annual profit at the top end of market expectations and said it had started a strategic review of its health business.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.